Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Breast Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 34 articles: HTML format

Single Articles

April 2026
1. FU W, Lin L, Li J, Qin F, et al
   Quercetin reduces expression of ATP?binding cassette transporters by regulating the PTEN/PI3K/AKT signaling pathway in breast cancer cells.
   Oncol Rep. 2026;55:63.
   PubMed     Abstract available
   
   
   
2. JIN Y, Zhang W, Wang H, Zhang Z, et al
   [Retracted] EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P?gp substrates in vitro and in vivo.
   Oncol Rep. 2026;55:61.
   PubMed     Abstract available
   
   
   
3. KOBAYASHI M, Konno C, Shimizu A, Kobayashi M, et al
   Tumor?associated glucocorticoid inhibition by mifepristone reduces polymorphonuclear myeloid?derived suppressor cells and promotes antitumor immunity in triple?negative breast cancer?bearing mice.
   Oncol Rep. 2026;55:60.
   PubMed     Abstract available
   
   
   
4. CHEN Y, Wei L, Zhang X, Liu X, et al
   [Corrigendum] 3?Bromopyruvate sensitizes human breast cancer cells to TRAIL?induced apoptosis via the phosphorylated AMPK?mediated upregulation of DR5.
   Oncol Rep. 2026;55:56.
   PubMed     Abstract available
   
   
   
5. YUAN Z, Sanders AJ, Ye L, Wang Y, et al
   [Retracted] Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP?9.
   Oncol Rep. 2026;55:73.
   PubMed     Abstract available
   
   
   March 2026
6. ALVARES-VILELA MM, Schlemmer F, Ferrari SSAR, Xavier ME, et al
   Role of tumor?infiltrating lymphocytes and miR?155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review).
   Oncol Rep. 2026;55:42.
   PubMed     Abstract available
   
   
   February 2026
7. ZHANG X, Zhang Y, Li Y
   [Retracted] beta?elemene decreases cell invasion by upregulating E?cadherin expression in MCF?7 human breast cancer cells.
   Oncol Rep. 2026;55:34.
   PubMed     Abstract available
   
   
   
8. ICHIHARA T, Hayashi Y, Sato T, Iguchi M, et al
   Hypoxia?mediated Krebs von den Lungen?6 expression in breast cancer: Implications for tumor invasion and metastasis.
   Oncol Rep. 2026;55:35.
   PubMed     Abstract available
   
   
   
9. YEN MC, Shih YC, Hsu YL, Lin ES, et al
   [Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR?30c in breast cancer.
   Oncol Rep. 2026;55:36.
   PubMed     Abstract available
   
   
   January 2026
10. MATSUNUMA R, Kinoshita K, Imada S, Sato S, et al
    CD44 knockdown and TGF?beta inhibition modulate cell proliferation and invasion in claudin?low breast cancer cells.
    Oncol Rep. 2026;55:7.
    PubMed     Abstract available
    
    
    
11. LI G, Jin B, Zhou J, Fang S, et al
    Immune system, inflammatory response, and regulated cell death in breast cancer research (Review).
    Oncol Rep. 2026;55:11.
    PubMed     Abstract available
    
    
    
12. JUNG E, Kim YJ, Lee K, Jang S, et al
    C?terminal HSP90 inhibitor NCT?58 impairs the cancer stem?like phenotype and enhances chemotherapy efficacy in TNBC.
    Oncol Rep. 2026;55:13.
    PubMed     Abstract available
    
    
    November 2025
13. LUO X, Wei Y, Lin H, Xiao N, et al
    BUB1B promotes homologous recombination?mediated DNA damage repair in breast cancer cells through the PI3K/AKT signaling pathway.
    Oncol Rep. 2025;54:147.
    PubMed     Abstract available
    
    
    
14. CHEN T, Sun S, Zhou Z, Zhang X, et al
    Ursolic acid: A natural pentacyclic triterpenoid with clinical promise in gynecological and breast cancers (Review).
    Oncol Rep. 2025;54:153.
    PubMed     Abstract available
    
    
    September 2025
15. LI T, Zhang C, Ding Y, Zhai W, et al
    [Corrigendum] Umbilical cord?derived mesenchymal stem cells promote proliferation and migration in MCF?7 and MDA?MB?231 breast cancer cells through activation of the ERK pathway.
    Oncol Rep. 2025;54:100.
    PubMed     Abstract available
    
    
    
16. CIARAMELLA V, Carrese B, Coppola L, Smaldone G, et al
    Evaluation of HMGB1 as possible marker via breast organoid cultures research.
    Oncol Rep. 2025;54:106.
    PubMed     Abstract available
    
    
    July 2025
17. ZUO X, Qin Y, Zhang X, Ning Q, et al
    [Retracted] Breast cancer cells are arrested at different phases of the cell cycle following the re?expression of ARHI.
    Oncol Rep. 2025;54:83.
    PubMed     Abstract available
    
    
    June 2025
18. XIAO L, Li J, Liao J, Wu M, et al
    BCL2A1? and G0S2?driven neutrophil extracellular traps: A protective mechanism linking preeclampsia to reduced breast cancer risk.
    Oncol Rep. 2025;53:64.
    PubMed     Abstract available
    
    
    March 2025
19. DU SM, Li N, Xu WJ, Liu K, et al
    Triple?negative breast cancer cell?derived piR?31115 promotes the proliferation and migration of endothelial cells via METTL3?mediated m6A modification of YAP1.
    Oncol Rep. 2025;53:34.
    PubMed     Abstract available
    
    
    February 2025
20. ZHANG X, Cui D, Sun W, Yang G, et al
    Regulation of the beta?catenin/LEF?1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion.
    Oncol Rep. 2025;53:22.
    PubMed     Abstract available
    
    
    January 2025
21. HAN R, Zhao J, Lu L
    [Retracted] MicroRNA?34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.
    Oncol Rep. 2025;53:8.
    PubMed     Abstract available
    
    
    
22. DAI X, Geng F, Li M, Liu M, et al
    [Corrigendum] Tripartite motif?containing 11 regulates the proliferation and apoptosis of breast cancer cells.
    Oncol Rep. 2025;53:5.
    PubMed     Abstract available
    
    
    
23. WANG YW, Tuan YL, Wang JY, Chang HY, et al
    Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer.
    Oncol Rep. 2025;53:16.
    PubMed     Abstract available
    
    
    December 2024
24. HU F, Zhang Y, Li M, Zhao L, et al
    [Corrigendum] BMP?6 inhibits the metastasis of MDA?MB?231 breast cancer cells by regulating MMP?1 expression.
    Oncol Rep. 2024;52:163.
    PubMed     Abstract available
    
    
    November 2024
25. SUN P, Huang H, Ma JC, Feng B, et al
    Repurposing propofol for breast cancer therapy through promoting apoptosis and arresting cell cycle.
    Oncol Rep. 2024;52:155.
    PubMed     Abstract available
    
    
    October 2024
26. CUI H, Yuan J, Du X, Wang M, et al
    [Corrigendum] Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt?NF?kappaB signaling.
    Oncol Rep. 2024;52:128.
    PubMed     Abstract available
    
    
    
27. ZHAO Z, Sun YS, Chen W, Lv LX, et al
    [Corrigendum] Hispolon inhibits breast cancer cell migration by reversal of epithelial?to?mesenchymal transition via suppressing the ROS/ERK/Slug/E?cadherin pathway.
    Oncol Rep. 2024;52:134.
    PubMed     Abstract available
    
    
    September 2024
28. QIU Y, Liu Y, Li WH, Zhang HQ, et al
    [Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT?related genes Snail and E?cadherin.
    Oncol Rep. 2024;52:111.
    PubMed     Abstract available
    
    
    August 2024
29. LIM JS, Kim E, Song JS, Ahn S, et al
    Energy?stress?mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple?negative breast cancer.
    Oncol Rep. 2024;52:101.
    PubMed     Abstract available
    
    
    
30. LI H, Li X, Du W
    Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review).
    Oncol Rep. 2024;52:107.
    PubMed     Abstract available
    
    
    
31. PENG X, Ma L, Chen X, Tang F, et al
    Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer.
    Oncol Rep. 2024;52:110.
    PubMed     Abstract available
    
    
    July 2024
32. YAO J, Xu T, Tian T, Fu X, et al
    [Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli?1 degradation via the ubiquitin?proteasome pathway.
    Oncol Rep. 2024;52:89.
    PubMed     Abstract available
    
    
    
33. YANG X, Liang B, Zhang L, Zhang M, et al
    Ursolic acid inhibits the proliferation of triple?negative breast cancer stem?like cells through NRF2?mediated ferroptosis.
    Oncol Rep. 2024;52:94.
    PubMed     Abstract available
    
    
    
34. ANWAR S, Zafar M, Hussain MA, Iqbal N, et al
    Unravelling the therapeutic potential of forkhead box proteins in breast cancer: An update (Review).
    Oncol Rep. 2024;52:92.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum